Desktop Metal Inc (NYSE: DM) has pronounced the expansion of its technology portfolio, and that is through the addition of the PhonoGraft™ platform. Since its establishment, it has been working towards the development of 3D printing and biofabrication solutions. The latest move is a step towards the right direction in efforts geared towards increasing the functional and morphological regeneration of the tympanic membrane.
The essence of the biofabrication technology
Experts opine that the technology could provide a good blueprint for soft tissue regeneration, which could apply to a huge diversity of healthcare applications.
Researchers seek to study and identify the possible application of PhonoGraft technology in an implantable device to determine whether or not it could assist with repairing damaged eardrums. The scientists also plan to employ a programmable biodegradable 3D printed graft, but they insist on less invasive. It will also be about providing patients with better services in terms of enjoying decreased procedure times.
Above all, there is a need to find a solution that ensures improved healing, and the hearing outcomes happen to be the other thing scientists wish to achieve in their undertakings. So the company embarks on the journey of discovery, hoping to find the best way to achieve soft tissue regeneration, and that should be on some diverse healthcare applications.
Jafar speaks out about the recent development
President and CEO of Desktop Health Michael Jafar considers the company’s latest pronouncement to be the start to something great. It is set to be a journey where the company succeeds in its quest to advance personalized medicine. In addition, he hopes that the platform will at some point provide a groundbreaking solution to many patients struggling with tympanic membrane perforation (TMP).
Jafar opines, “PhonoGraft material technology, coupled with our leading biofabrication capabilities, has tremendous potential across a wide range of healthcare applications in soft tissue – from cardiovascular and neuronal grafts to plastic surgery.”